Drug Target Review

APRIL 5, 2024

However, there is significant variability within the various CHO cell lines, and CDMOs often have differing levels of success in optimising their cells for protein production. They’re prepared for complexity Successful expression of the gene of interest is not sufficient on its own for large-scale production.

Protein Production 96

Protein Production Protein Expression Bioinformatics Production 96

Broad Institute

MAY 14, 2024

Then, during graduate school at the California Institute of Technology in the early 1960s, he was introduced to bacteriophage T7, a virus that infects Escherichia coli bacteria. Driven by basic biology Studier grew up in Iowa and became fascinated with biophysics while an undergraduate at Yale University. and around the world.

RNA 84

RNA Production Molecular Biology Laboratories 84

The Pharma Data

JANUARY 13, 2021

Germany-based Cevec Pharmaceuticals GmbH signed a licensing agreement with Biogen for the use of its proprietary ELEVECTA Technology for the manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications. The deal will provide Biogen the rights to use the technology across their portfolio of gene therapy products.

Licensing 52

Licensing Licensing Clinical Trials Trials 52